A detailed history of Sound View Wealth Advisors Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 2,044 shares of REGN stock, worth $1.59 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,044
Previous 1,961 4.23%
Holding current value
$1.59 Million
Previous $2.06 Million 4.22%
% of portfolio
0.18%
Previous 0.21%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1024.09 - $1201.76 $84,999 - $99,746
83 Added 4.23%
2,044 $2.15 Million
Q2 2024

Aug 05, 2024

SELL
$883.2 - $1071.19 $170,457 - $206,739
-193 Reduced 8.96%
1,961 $2.06 Million
Q1 2024

May 09, 2024

SELL
$902.69 - $993.35 $34,302 - $37,747
-38 Reduced 1.73%
2,154 $2.07 Million
Q4 2023

Feb 08, 2024

BUY
$775.18 - $881.7 $7,751 - $8,817
10 Added 0.46%
2,192 $1.93 Million
Q3 2023

Nov 07, 2023

BUY
$692.45 - $844.37 $51,933 - $63,327
75 Added 3.56%
2,182 $1.8 Million
Q2 2023

Aug 08, 2023

BUY
$700.03 - $830.35 $23,801 - $28,231
34 Added 1.64%
2,107 $1.51 Million
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $1.02 Million - $1.24 Million
1,498 Added 260.52%
2,073 $1.7 Million
Q4 2022

Feb 08, 2023

SELL
$705.89 - $766.39 $993,187 - $1.08 Million
-1,407 Reduced 70.99%
575 $414,000
Q3 2022

Nov 08, 2022

BUY
$573.97 - $724.32 $35,586 - $44,907
62 Added 3.23%
1,982 $1.37 Million
Q2 2022

Aug 05, 2022

SELL
$548.35 - $738.84 $548 - $738
-1 Reduced 0.05%
1,920 $1.14 Million
Q1 2022

May 11, 2022

SELL
$595.12 - $698.43 $19,043 - $22,349
-32 Reduced 1.64%
1,921 $1.34 Million
Q4 2021

Jan 20, 2022

SELL
$543.48 - $670.97 $1,086 - $1,341
-2 Reduced 0.1%
1,953 $1.23 Million
Q3 2021

Oct 21, 2021

BUY
$574.03 - $680.96 $1,148 - $1,361
2 Added 0.1%
1,955 $1.18 Million
Q2 2021

Jul 21, 2021

BUY
$472.8 - $558.54 $9,456 - $11,170
20 Added 1.03%
1,953 $1.09 Million
Q1 2021

Apr 28, 2021

SELL
$446.73 - $548.2 $10,274 - $12,608
-23 Reduced 1.18%
1,933 $915,000
Q4 2020

Feb 02, 2021

BUY
$478.3 - $607.98 $1,913 - $2,431
4 Added 0.2%
1,956 $945,000
Q3 2020

Nov 09, 2020

SELL
$544.75 - $658.21 $13,618 - $16,455
-25 Reduced 1.26%
1,952 $1.09 Million
Q2 2020

Aug 07, 2020

SELL
$493.32 - $643.92 $65,118 - $84,997
-132 Reduced 6.26%
1,977 $1.23 Million
Q1 2020

May 12, 2020

SELL
$336.18 - $494.43 $20,506 - $30,160
-61 Reduced 2.81%
2,109 $1.03 Million
Q4 2019

Jan 27, 2020

SELL
$274.13 - $376.51 $6,579 - $9,036
-24 Reduced 1.09%
2,170 $815,000
Q3 2019

Nov 07, 2019

SELL
$273.46 - $318.39 $9,024 - $10,506
-33 Reduced 1.48%
2,194 $609,000
Q2 2019

Aug 07, 2019

BUY
$299.6 - $414.82 $667,209 - $923,804
2,227 New
2,227 $697,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sound View Wealth Advisors Group, LLC Portfolio

Follow Sound View Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound View Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound View Wealth Advisors Group, LLC with notifications on news.